US Bancorp
IMCR icon

US Bancorp’s Immunocore IMCR Stock Holding History

US Bancorp’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-264
Closed -$7.96K – 4260
2026
Q1 		$7.96K Hold
264
– – ﹤0.01% 3432
2025
Q4 		$9.16K Hold
264
– – ﹤0.01% 3365
2025
Q3 		$9.59K Hold
264
– – ﹤0.01% 3327
2025
Q2 		$8.28K Sell
264
-46
-15% -$1.43K ﹤0.01% 3488
2025
Q1 		$9.2K Hold
310
– – ﹤0.01% 3465
2024
Q4 		$9.14K Sell
310
-3
-1% -$95 ﹤0.01% 3445
2024
Q3 		$9.74K Sell
313
-977
-76% -$35.5K ﹤0.01% 3371
2024
Q2 		$43.7K Buy
1,290
+104
+9% +$5.3K ﹤0.01% 2739
2024
Q1 		$77.1K Buy
1,186
+927
+358% +$63.6K ﹤0.01% 2484
2023
Q4 		$17.7K Sell
259
-62
-19% -$3.22K ﹤0.01% 3115
2023
Q3 		$16.7K Buy
321
+71
+28% +$4.2K ﹤0.01% 2968
2023
Q2 		$15K Buy
+250
New +$14.3K ﹤0.01% 3106

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

US Bancorp's IMCR Position: Q2 2026 in Review

US Bancorp sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 264 shares — an estimated $7.96K sold.

US Bancorp first reported a position in IMCR in Q2 2023 and held it in 12 quarters. The position peaked at $77.1K in Q1 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • US Bancorp reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 264 Immunocore shares in Q2 2026, an estimated $7.96K.
  • US Bancorp first reported a position in Immunocore in Q2 2023 and held it in 12 quarters.
  • US Bancorp's Immunocore position peaked at $77.1K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.